Kingson Pharmaceuticals Private Limited
About Kingson Pharmaceuticals Private Limited
Data last updated:
Kingson Pharmaceuticals Private Limited is a private limited company based in Bhopal, Madhya Pradesh, India. It operates in the wholesale trading and distribution segment of the trading and commerce sector. It was incorporated on 04 June 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24232MP2014PTC032745. Its GSTIN is 23AAFCK5860J1ZE (Madhya Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Kalpana Gautam and Om Namo Narayan Dwivedi.
Its last annual general meeting (AGM) was held on 10 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 290/02 Sai Dham Colony Neelbad Huzur, Bhopal, Madhya Pradesh, India – 462044.
As per the financials filed for FY 2025, the company reported a revenue of ₹15.84 Lakh, a growth of 50% compared to the previous year. For the same year it recorded a net profit of ₹11,691 (net margin 0.7%) and EBITDA of ₹76,369 (EBITDA margin 4.8%). Revenue has grown at a compounded annual rate (CAGR) of 24% over three years and 20% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Kingson Pharmaceuticals Private Limited's registered office is in Bhopal, Madhya Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address290/02 Sai Dham Colony Neelbad Huzur, Bhopal, Madhya Pradesh, India – 462044
- IndustryTrading, Wholesale, Other Wholesale
To see the full contact details of Kingson Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Kingson Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Kingson Pharmaceuticals Private Limited, buy the company report.
Financials of Kingson Pharmaceuticals Private Limited
FY 2025 filings availableKingson Pharmaceuticals Private Limited reported revenue of ₹15.84 Lakh (up 50% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 20% over five years, including 50% growth in the latest year. EBITDA fell 18% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹76,369 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹11,691 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.8% | ||||
| Net Profit Margin | 0.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Kingson Pharmaceuticals Private Limited, buy the company report.
Board of directors of Kingson Pharmaceuticals Private Limited
Kingson Pharmaceuticals has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kalpana Gautam | Director | 11 Jul 2022 | 4 Years 3 Months | Current |
| Om Namo Narayan Dwivedi | Director | 14 Jul 2021 | 5 Years 3 Months | Current |
Peer comparison
Kingson Pharmaceuticals Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Rivexia Pharmaceuticals Private Limited | ₹15.91 Lakh (FY 2024) | 12.0% | New Delhi, Delhi, India | |||
| Sitaman Pharmaceuticals Private Limited | ₹15.87 Lakh (FY 2025) | -64.0% | Mumbai, Maharashtra, India | |||
| Ziva Pharmaceuticals Private Limited | ₹15.84 Lakh (FY 2020) | 35.0% | Gurgaon, Haryana, India | |||
| Kingson Pharmaceuticals Private Limitedthis company | ₹15.84 Lakh (FY 2025) | ₹11,691 | 0.7% | 50.0% | Bhopal, Madhya Pradesh, India | |
| Means Pharmaceuticals Private Limited | ₹15.82 Lakh (FY 2025) | 56.0% | Delhi, India | |||
| Yskp Pharmaceuticals Private Limited | ₹15.65 Lakh (FY 2025) | -3.0% | Thane, Maharashtra, India | |||
| Rolex Pharmaceuticals Limited | ₹15.63 Lakh (FY 2022) | 180.0% | Vadodara, Gujarat, India |
To see the full peer comparison of Kingson Pharmaceuticals Private Limited, buy the company report.
Auditor
Kingson Pharmaceuticals Private Limited is audited by Y.N. GUPTA & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Y.N. GUPTA & ASSOCIATES | FY 2017 | 016289 |
Shareholding
The shareholding of Kingson Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Kingson Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Kingson Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Kingson Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Kingson Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AAFCK5860J1ZE | Madhya Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Kingson Pharmaceuticals Private Limited, buy the company report.
Recent activity
Kingson Pharmaceuticals Private Limited has 6 board changes on record since 2021: 2 appointments and 4 cessations. The latest: Ashvani Kumar Dwivedi ceased to be Director on 06 Jan 2023.
Frequently asked questions
Kingson Pharmaceuticals is an active private limited company based in Bhopal, Madhya Pradesh, India. The company works in wholesale, within the trading industry. It was incorporated on 04 June 2014 (12+ years old) and is registered under CIN U24232MP2014PTC032745.
Kingson Pharmaceuticals has 2 current directors:
- Kalpana Gautam - Director
- Om Namo Narayan Dwivedi - Director
The latest financial statements of Kingson Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 10 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Kingson Pharmaceuticals is 23AAFCK5860J1ZE, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Kingson Pharmaceuticals is U24232MP2014PTC032745. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Kingson Pharmaceuticals was incorporated on 04 June 2014, making it 12+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Kingson Pharmaceuticals by revenue are Rivexia Pharmaceuticals Private Limited, Sitaman Pharmaceuticals Private Limited, Ziva Pharmaceuticals Private Limited, Means Pharmaceuticals Private Limited, Yskp Pharmaceuticals Private Limited and 1 more, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Ashvani Kumar Dwivedi ceased to be Director on 06 Jan 2023. Kalpana Gautam was appointed as Director on 11 Jul 2022. Ashok Kumar Dubey ceased to be Additional Director on 30 Nov 2021. Kingson Pharmaceuticals has 6 board changes on record in total.
The registered office of Kingson Pharmaceuticals is at 29002 Sai Dham Colony Neelbad Huzur, Bhopal, Madhya Pradesh, India – 462044.
Kingson Pharmaceuticals operates in the trading industry, in the wholesale segment.
The compliance status of Kingson Pharmaceuticals is compliant as of 08 September 2026. The company is actively filing with the Registrar of Companies.